Golden Brain Care, an AI-powered speech rehabilitation startup, has raised seed funding from Series Ventures, a venture capital firm focused on the Southeastern region. The undisclosed investment will support the expansion of Brain Friends, a comprehensive AI-based speech rehabilitation platform.
TL;DR
- Golden Brain Care raises seed funding from Series Ventures to expand Brain Friends platform.
- Brain Friends integrates language function assessment, personalized rehabilitation training, and performance data analysis.
- The investment will support the company's phased business strategy, including clinical validation and expansion into digital therapeutics.
What happened
Golden Brain Care, founded in Busan in 2026, develops Brain Friends, an AI-based speech rehabilitation platform for patients with neurological conditions such as stroke, brain injury, and dementia. The platform integrates language function assessment, personalized rehabilitation training, performance data analysis, and caregiver reporting in a single workflow.
Series Ventures, a venture capital firm focused on the Southeastern region, has completed a seed round investment in Golden Brain Care. The investment amount was not disclosed.
The company's team combines field expertise in speech rehabilitation with AI technology development capabilities. CEO Hyunsong Lee holds a Class 1 Speech-Language Pathologist certification and is designing services based on field experience.
Golden Brain Care has been selected for Konyang University Hospital's clinical data AI demonstration project, Korea Testing Laboratory (KTL) demonstration technology services, and full-cycle technical support for innovative medical device safety management.
Why it matters
The number of cerebrovascular disease patients in South Korea exceeds one million, many of whom experience communication disorders. Speech rehabilitation is a domain where specialist observation and assessment carry significant weight, but traditional methods have limitations in managing repetitive training and systematic data accumulation.
Golden Brain Care's technology quantitatively manages the speech rehabilitation process by analyzing voice, facial movement, and response data with AI. The platform aims to enhance the continuity and accessibility of rehabilitation, enabling training and management to continue in everyday environments.
The company's phased business strategy includes validating business viability in public voucher markets and institutional SaaS, followed by accumulating clinical evidence and licensing foundations for expansion into digital therapeutics areas that require medical device licensing.
Key facts
- Golden Brain Care raises seed funding from Series Ventures to expand Brain Friends platform.
- Brain Friends integrates language function assessment, personalized rehabilitation training, and performance data analysis.
- The company's team combines field expertise in speech rehabilitation with AI technology development capabilities.
- Golden Brain Care has been selected for Konyang University Hospital's clinical data AI demonstration project, KTL demonstration technology services, and full-cycle technical support for innovative medical device safety management.
- The company's business strategy includes validating business viability in public voucher markets and institutional SaaS, followed by expanding into digital therapeutics areas that require medical device licensing.
- CEO Hyunsong Lee holds a Class 1 Speech-Language Pathologist certification and is designing services based on field experience.
- The number of cerebrovascular disease patients in South Korea exceeds one million, many of whom experience communication disorders.
- Golden Brain Care is pursuing the application of on-device AI technology to minimize external transmission of sensitive information such as voice and facial video.
Context
The growing demand for digital solutions in speech rehabilitation is driven by the limitations of traditional methods in managing repetitive training and systematic data accumulation. AI-powered platforms like Brain Friends offer the potential to enhance the continuity and accessibility of rehabilitation, enabling training and management to continue in everyday environments.
The investment in Golden Brain Care by Series Ventures highlights the potential of AI-powered speech rehabilitation solutions in addressing the needs of patients with neurological conditions. The company's phased business strategy and clinical validation efforts position it for expansion into digital therapeutics areas that require medical device licensing.
The broader AI landscape in healthcare is witnessing significant growth, with startups leveraging AI technology to develop innovative solutions for various medical conditions. The investment in Golden Brain Care is a testament to the potential of AI-powered platforms in transforming speech rehabilitation and improving patient outcomes.
